Products for Research Use Only
RegisterLogin

Bardoxolone (CDDO)

CAT: 0957-S6647-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0957-S6647-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Bardoxolone (CDDO), acts by releasing Nrf2 from KEAP1, is a highly potent activator of Nrf2 that induce programmed cell death (apoptosis) in cancer cells.
CAS Number
218600-44-3
Synonyms
RTA 401
Target
Nrf2
Activity
NF-κB
Molecular Formula
C31H41NO4
Storage Conditions
3 years -20°C powder

Related Products

CatalogName
S8078-25mgBardoxolone Methyl
S8078-1gBardoxolone Methyl
S8078-200mgBardoxolone Methyl
S8078-01Bardoxolone Methyl
E7632-1mgCDDO-EA
E7632CDDO-EA
S9723-5mgCDDO-Im (RTA-403)
S9723-01CDDO-Im (RTA-403)
S9723-25mgCDDO-Im (RTA-403)
S9723-100mgCDDO-Im (RTA-403)

Alternative Products

CatalogName
S6647-25mgBardoxolone (CDDO)
A11324-50Bardoxolone (CDDO) 50mg
A11324-10Bardoxolone (CDDO) 10mg
A11324-5Bardoxolone (CDDO) 5mg
A11324-100Bardoxolone (CDDO) 100mg
A11324-25Bardoxolone (CDDO) 25mg
A11324-10mM-DBardoxolone (CDDO) 10mM * 1mL in DMSO
217264CDDO-Me (NSC 713200, Bardoxolone Methyl, BARD, Methyl-2-cyano-3,12-dioxooleana-1,9 (11) -dien-28-oate)
FLB29884-01Bardoxolone

Popular Products